10 Jan, 2012
HyTest’s strong growth continues
HyTest’s revenue at the end of October for the fiscal year 2010-2011 year was EUR 10.2 million. HyTest was again capable of growing its market share as growth over the previous year was 12% which exceeds the industry average.
Read more
21 Jun, 2011
HyTest abstract has won National Academy of Clinical Biochemistry Distinguished Abstract Award
HyTest attends to AACC 2011 Clinical Expo in Atlanta, July 25-28. You are warmly welcome to visit our booth #27 at any time.
Read more
25 May, 2011
HyTest revenue increased 15 % - press release first half of fiscal year 2011
Sales of cardiac markers increased significantly during the period and there was especially remarkable growth in the sales of troponin-products.
Read more
14 Feb, 2011
Licensing opportunities – technology solution for BNP- and proBNP -detection
Interested in entering the fast growing cardiac diagnostics market with a new innovative diagnostics solution?
Read more
05 Feb, 2011
Strong growth of HyTest continues – revenue almost 10 million euros
HyTest revenue increased by 17% to 9.1 million euros and the operating profit was 3.1 million euros and in percentage 34%.
Read more
17 May, 2010
D-dimer and High Molecular Weight Fibrin Degradation
HyTest offers D-dimer produced from clotted fibrinogen by means of plasmin digestion and anti-D-dimer MAbs.
Read more
15 Apr, 2010
Antibodies for New Type of BNP immunoassay – “Single Epitope Sandwich” assay
HyTest specialists have recently developed antibodies for a brand new type of BNP immunoassay
Read more

Sign up to our newsletter

And be informed about new products and scientific findings

Thank you for your subscription!